Cargando…
Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to the coronavirus disease (COVID-19) outbreak that became a pandemic in 2020, causing more than 30 million infections and 1 million deaths to date. As the scientific community has looked for vaccines and drugs to treat or eliminat...
Autores principales: | Yiangou, Loukia, Davis, Richard P., Mummery, Christine L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833904/ https://www.ncbi.nlm.nih.gov/pubmed/33306986 http://dx.doi.org/10.1016/j.stemcr.2020.11.003 |
Ejemplares similares
-
Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research
por: Mummery, Christine L.
Publicado: (2018) -
Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties
por: van den Brink, Lettine, et al.
Publicado: (2020) -
STRAIGHT-IN enables high-throughput targeting of large DNA payloads in human pluripotent stem cells
por: Blanch-Asensio, Albert, et al.
Publicado: (2022) -
Cell cycle regulators control mesoderm specification in human pluripotent stem cells
por: Yiangou, Loukia, et al.
Publicado: (2019) -
Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research
por: Mascetti, Victoria L., et al.
Publicado: (2016)